Navigation Links
Immunosyn Announces the Successful Completion of First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
Date:1/17/2008

Trial" and with the absence of any adverse side effects, the trial will go forward to the next phase and will be expanded to cover a wider group of patients."

It is expected that the next phase will be completed during the first half of 2008 and that larger-scale independently-managed formal Clinical Trials, leading to a licensed product in Europe, will take place shortly thereafter at a world-renowned specialist wound healing clinic.

"The success of this phase of the trial is yet another substantial milestone in moving toward approval of SF-1019 in Europe for use with Diabetic Ulcers," said Stephen D. Ferrone, President and CEO of Immunosyn. "We feel that beyond whatever the potential revenue might be for Immunosyn, from possible future approval and sales of SF-1019, is the significant and compassionate role that SF-1019 could eventually play in filling an unmet need in the arena of wound healing. According to the International Diabetes Federation (IDF), of the 250 million people globally who suffer from Diabetes Mellitus one out of six will develop a Diabetic Ulcer. To put that into perspective, currently, worldwide, one person every 30 seconds has a limb amputated due to Diabetes, 85% of which are preceded by a Diabetic Ulcer; and, as unbelievable as it seems, until now there have been no known therapies to remedy this tragic condition," concluded Mr. Ferrone.

About Immunosyn Corporation

La Jolla, CA-headquartered Immunosyn Corporation (IMYN.OTC.BB) plans to market and distribute life enhancing therapeutics. Currently, the company has exclusive worldwide rights from its largest shareholder, Argyll Biotechnologies, LLC, to market, sell and distribute SF-1019, a compound that was developed from extensive research into Biological Response Modifiers (BRMs). Argyll Biotechnologies, LLC has initiated the process for regulatory approval of SF-1019 in several countries and preparations for clinical trials are underway in both the US and Europ
'/>"/>

SOURCE Immunosyn Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Immunosyn Corporation Names Stephen Ferrone as CEO
2. Immunosyn Corporation to Begin Trading
3. Equity Research Firm Issued Unauthorized Report and Press Release on Immunosyn Corporation Today
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Steven Reinberg HealthDay Reporter ... rare birth disorder that dismantles a baby,s immune system is ... more than 3 million infants says. This is the ... life-threatening but treatable condition known as severe combined immunodeficiency (SCID), ... made aware of this condition by the boy in the ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 The main feature ... per diode panel band perfect spectrum that encompasses the most ... likely to use during photosynthesis. A key point about ... that they almost exclusively reside between 440-480 on the blue ... red side of the spectrum. The KIND LED K3 focuses ...
(Date:8/20/2014)... August 20, 2014 Braverman Eye Center ... help of their experienced surgeons trained in PresbyLasik. The ... regain their lost or inaccurate vision. Their diligent service ... surgery is making it possible for Presbyopia patients to ... occurs normally in people in the age group of ...
(Date:8/20/2014)... August 20, 2014 The Academy of ... Lokhandwala, DDS, FAGD of Starbrite Dental in Fremont, California, ... 2014 Annual Meeting & Exhibits, which took place June ... presented to dentists who seek to provide the highest-quality ... earn this prestigious honor, Dr. Lokhandwala completed 500 hours ...
(Date:8/20/2014)... anniversary of a revolutionary technique that underpins much of ... magazine last week released a special edition on X-ray ... of its future. C&EN is the weekly news magazine ... scientific society. , The technique got its start when ... on X-ray diffraction from a crystal in 1912. In ...
Breaking Medicine News(10 mins):Health News:'Bubble Boy' Disease May Be More Common Than Thought 2Health News:'Bubble Boy' Disease May Be More Common Than Thought 3Health News:Cheap LED Grow Lights Are Quickly Being Replaced by Premium Grow Lights 2Health News:Braverman Eye Center Now Offers Multifocal PresbyLasik in Florida by Trained Surgeons 2Health News:Fremont Dentist Receives Prestigious AGD Fellowship Award 2
... disorders in Paris discussed the ongoing research on development of ... the more than a century old test that takes a ... of TB have become resistant. , According to ... congress of the Union for breathing health and executive director ...
... people with symptoms similar to the mosquito-borne dengue fever are ... Monday. // ,The number of patients with dengue-like ... been declared positive for the virus across the country., ... in Pakistan - 32 in Sindh province alone. The other ...
... States, 23.5 million children travel billions of miles on ... Injury Research and Policy (CIRP) at Columbus// Children’s Hospital ... describe nonfatal school bus-related injuries to children and teenagers ... ,According to the study, published in the November ...
... vaccines.// ,Getting into the new era of ... children for influenza might cost up to three or ... ,The researchers from Pediatric department of Philadelphia ... justification for broadly vaccinating the children against flu’. ...
... study has established the wholesomeness of whole wheat as ... cancer risk in the offspring.// ,Dr Leena ... colleagues examined the benefits of dietary changes on pregnant ... These results could well mimic the occurrence in humans, ...
... According to a global study on effective primary health ... Fund, Canada ranks much lower than other developed// countries, ... on over 6,000 doctors in 7 countries, it was ... times for tests, usage of electronic medical records, doctors ...
Cached Medicine News:Health News:Nonfatal School Bus-Related Injuries To Children More Common Than Previously Thought 2Health News:Unconventional Hospital Costs For Children Affected By Flu 2
(Date:8/20/2014)... Aug. 20, 2014 Research and ... "Global Advanced Wound Care and Closure Market ... Share, Global Trends, Company Profiles, Demand, Insights, Analysis, ... 2020" report to their offering. ... care and closure market (types, applications, end user ...
(Date:8/20/2014)... Mich. and PHOENIX ... corporation established to bring cutting-edge next-generation sequencing and ... cancer patients, today announced a collaboration with TESARO, ... to characterize patient tissue samples from clinical trials ... or resistant to TESARO,s TSR-011.  This may lead to ...
(Date:8/20/2014)... , Aug. 20, 2014  Glades Drugs, an independent pharmacy ... proud to announce its expansion into a new corporate headquarters ... feature an 8,000-square-foot office space and state of the art ... for 100 open positions for the new facility. ... Road will serve as the chain,s corporate headquarters and closed ...
Breaking Medicine Technology:Global Advanced Wound Care and Closure Market (Types, Applications, End User and Geography) - Forecast to 2020 2Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2
Inquire...
... collection features a range of 18 ... modern materials and producted to the ... includes several super lightweight Titanium and ... a whole host of beautifully formed ...
... collection features a variety of colors ... of feminine styles designed with elegant ... men and women that are made ... as used in our fine timepieces, ...
... together a remarkable sunwear collection, affectionately known ... all of the benefits of the Titan ... with top quality sun lenses that offer ... protection. They provide the most comfortable, lightweight ...
Medicine Products: